Press Releases CONMED Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 11:56:57 2024-04-29 am EDT			5-day change	1st Jan Change
66.32 ^USD	+0.82%		-8.51%	-39.34%

Apr. 25	Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	MT
Apr. 25	Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	MT

Conmed: Q1 Earnings Snapshot	Apr. 24	AQ
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer	Apr. 24	BU
CONMED Corporation Announces First Quarter 2024 Financial Results	Apr. 24	BU
CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024	Apr. 02	BU
CONMED Corporation Announces Quarterly Cash Dividend	Feb. 27	BU
Conmed: Q4 Earnings Snapshot	Jan. 31	AQ
CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results	Jan. 31	BU
CONMED Corporation to Announce Fourth Quarter 2023 Financial Results on January 31, 2024	Jan. 03	BU
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference	Dec. 21	BU
CONMED Corporation Announces Quarterly Cash Dividend	Dec. 05	BU
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference	Nov. 13	BU
CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 14-15	23-10-31	BU
Conmed: Q3 Earnings Snapshot	23-10-25	AQ
CONMED : Investor Presentation	23-10-25	PU
CONMED Corporation Announces Third Quarter 2023 Financial Results	23-10-25	BU
CONMED Corporation to Announce Third Quarter 2023 Financial Results on October 25, 2023	23-10-04	BU
CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference	23-09-05	BU
CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare Conference	23-08-24	BU
CONMED Corporation Announces Quarterly Cash Dividend	23-08-10	BU
Conmed: Q2 Earnings Snapshot	23-07-26	AQ

No results for this search